- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Clinicopathological significance of lymphangiogenesis detected by immunohistochemistry using D2-40 monoclonal antibody in breast cancer
-
- Abe Noriko
- Department of Organ Regulatory Surgery, Fukushima Medical University
-
- Ohtake Tohru
- Department of Organ Regulatory Surgery, Fukushima Medical University
-
- Saito Katsuharu
- Department of Organ Regulatory Surgery, Fukushima Medical University
-
- Kumamoto Kensuke
- Department of Organ Regulatory Surgery, Fukushima Medical University
-
- Sugino Takashi
- Division of Diagnostic Pathology, Shizuoka Cancer Center Hospital
-
- Takenoshita Seiichi
- Department of Organ Regulatory Surgery, Fukushima Medical University
Search this article
Description
To elucidate the association between the lymphangiogenesis and clinicopathological factors including the survival in breast cancer, 91 Japanese patients with breast cancer were investigated. The lymphangiogenesis was evaluated by the count of lymph vessel density (LVD) with immunohistochemical method using D2-40 monoclonal antibody, a specific marker for lymphatic endothelial cells.<br>D2-40-positive lymph vessels were detected in 87 of 91 cases, and were mainly distributed in the peritumoral lesions or around the tumor edge. There was a significant difference in disease-free survival (DFS) and overall survival (OS) between patients with high LVD and with low LVD (p=0.02, 0.01, respectively, log-rank test). In addition, LVD significantly correlated with the following clinicopathological factors: menopausal status (p<0.01), tumor size (p<0.01), lymph-node status (p=0.01) lymphatic vessel invasion (LVI) (p<0.01), blood vessel invasion (BVI) (p=0.03) and estrogen receptor status (ER) (p=0.02).<br>Those data suggest that D2-40 monoclonal antibody is a useful marker for evaluating the LVD and its evaluation is helpful to predict the survival in breast cancer.
Journal
-
- FUKUSHIMA JOURNAL OF MEDICAL SCIENCE
-
FUKUSHIMA JOURNAL OF MEDICAL SCIENCE 62 (1), 57-63, 2016
THE FUKUSHIMA SOCIETY OF MEDICAL SCIENCE
- Tweet
Details 詳細情報について
-
- CRID
- 1390001206306543360
-
- NII Article ID
- 130005156337
-
- NII Book ID
- AA0065246X
-
- ISSN
- 21854610
- 00162590
-
- PubMed
- 27210308
-
- Text Lang
- en
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- IRDB
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- Abstract License Flag
- Disallowed